Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Prostatic Neoplasms 4Brain Neoplasms 4Pancreatic Neoplasms 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Lung Neoplasms 2Glioma 2Esophageal Neoplasms 2Craniopharyngioma 2Wilms Tumor 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Resectable Lung Non-Small Cell Carcinoma 1Recurrent Head and Neck Carcinoma 1Radiation Injuries 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Meningioma 1Gliosarcoma 1Eye Neoplasms 1Ependymoma 1Desmoplastic Small Round Cell Tumor 1Chordoma 1Chondrosarcoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Temozolomide 46Radiotherapy 36Bevacizumab 34Carmustine 13Erlotinib Hydrochloride 11Irinotecan 10sargramostim 7Thalidomide 7Chemotherapy, Adjuvant 7Carboplatin 7Radiation 6pembrolizumab 5Topotecan 5Magnetic Resonance Spectroscopy 5Filgrastim 5Drug Therapy 5Cyclophosphamide 5aldesleukin 4Tamoxifen 4Surgical Procedures, Operative 4Sorafenib 4O(6)-benzylguanine 4Gefitinib 4Etoposide 4Celecoxib 4cediranib 3Radiotherapy, Intensity-Modulated 3Radiotherapy, Conformal 3Peripheral Blood Stem Cell Transplantation 3Imatinib Mesylate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Gliosarcoma × Proton Therapy × Clear all
NCT01730950 2022-12-29

Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma

Radiation Therapy Oncology Group

Phase 2 Completed
182 enrolled 19 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡